Se connecter Inscription gratuite

180 Life Sciences Objectif d'un an

Quel est le Objectif d'un an de 180 Life Sciences?

Le Objectif d'un an de 180 Life Sciences Corp. est $4 +127.27%

Quelle est la définition de Objectif d'un an?

La cible sur un an est un cours de bourse prévu dans un an.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

Objectif d'un an des entreprises dans Health Care secteur sur NASDAQ par rapport à 180 Life Sciences

Que fait 180 Life Sciences?

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Entreprises avec objectif d'un an similaire à 180 Life Sciences